The Centers for Disease Control and Prevention (CDC), operating under the U.S. Department of Health and Human Services, has issued a funding opportunity titled RFA-CC-18-000. This opportunity falls under the CDC’s ERA (Extramural Research Award) branch and supports initiatives under the injury prevention and control research domain. The cooperative agreement is designed to provide strategic funding to applicants advancing health outcomes through evidence-based interventions focused on injury prevention and related public health initiatives.
This funding opportunity is categorized as discretionary and uses a cooperative agreement funding instrument, suggesting close collaboration between the CDC and award recipients. It is aligned with Assistance Listings number 93.136, which pertains to Injury Prevention and Control Research and State and Community Based Programs. While the general intent and scope of fund use are not detailed in the available synopsis, programs under this listing typically support activities such as injury surveillance, prevention planning, education campaigns, and partnerships between research institutions and public health bodies.
Eligibility for this funding is broad, encompassing states, counties, universities, small businesses, and nonprofit organizations. The cooperative agreement may support a wide range of interventions, and although the exact eligible uses are unspecified, they likely relate to injury prevention strategies and capacity-building in public health systems. No cost-sharing or matching funds are required for this funding opportunity.
Applicants are advised to submit Type 6 applications as necessary. The application process is facilitated via Grants.gov, and while further specifics on submission steps, required forms, or evaluation criteria are not present in the synopsis, all applications should conform to federal standards and deadlines posted in the opportunity listing.
The current application window extends until September 30, 2030, providing a long-term horizon for interested applicants. This opportunity appears to recur on a rolling basis as suggested by the updated and future-dated closing deadline, indicating that applicants may apply at different times before the final cutoff. For assistance, Linton C. Browning is the designated contact and may be reached at 770-488-2756 or via email at lbrowning@cdc.gov. The estimated number of awards is up to 100, but no specific award ceiling, floor, or total program funding amount is provided in the current synopsis.
